DNA · Company research
Ginkgo Bioworks Holdings, Inc. (DNA): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 11.47 | $568,441,179 | 424577179.00 | — | — | — | 17.0212354473589651 | 1.2827199161463422 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.